R-Mini-CHOP Versus R-Bendamustine As Primary Treatment for Diffuse Large B-Cell Lymphoma (DLBCL) in Elderly and Comorbid Patients

被引：5
|
作者：
Hammersen, Jakob [1 ]
Ruethrich, Maria Madeleine [2 ]
Kleber, Martina [3 ]
Wedding, Ulrich [2 ]
Sommer, Michael [4 ]
Mueller, Daniela [2 ]
Schlattmann, Peter [2 ]
Hochhaus, Andreas [2 ]
La Rosee, Paul [2 ]
机构：
[1] Univ Hosp, Jena, Germany
[2] Univ Hosp Jena, Jena, Germany
[3] Univ Basel Hosp, CH-4031 Basel, Switzerland
[4] Universityhosp Jena, Jena, Germany
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
10.1182/blood.V124.21.5436.5436
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Subgroups of Diffuse Large B-Cell Lymphoma (DLBCL) with Different Genomic Lesions and Clinical Course During Treatment with R-CHOP
    Scandurra, Marta
    Mian, Michael
    De Campos, Cassio P.
    Rancoita, Paola M. V.
    Greiner, Timothy C.
    Chan, Wing C.
    Vose, Julie M.
    Inghirami, Giorgio
    Chiappella, Annalisa
    Baldini, Luca
    Ponzoni, Maurilio
    Ferreri, Andres J. M.
    Montes Moreno, Santiago
    Piris, Miguel A.
    Franceschetti, Silvia
    Gaidano, Gianluca
    Facchetti, Fabio
    Tucci, Alessandra
    Lazure, Thierry
    Lambotte, Olivier
    Uccella, Silvia
    Tibiletti, Maria Grazia
    Pinotti, Graziella
    Pruneri, Giancarlo
    Martinelli, Giovanni
    Nomdedeu, Josep F.
    Chigrinova, Ekaterina
    Rinaldi, Andrea
    Zucca, Emanuele
    Kwee, Ivo
    Bertoni, Francesco
    BLOOD, 2009, 114 (22) : 1521 - 1521
  • [32] Outcome of patients with primary refractory diffuse large B cell lymphoma after R-CHOP treatment
    Felicitas Hitz
    J. M. Connors
    R. D. Gascoyne
    P. Hoskins
    A. Moccia
    K. J. Savage
    L. H. Sehn
    T. Shenkier
    D. Villa
    R. Klasa
    Annals of Hematology, 2015, 94 : 1839 - 1843
  • [33] Managing early failures with R-CHOP in patients with diffuse large B-cell lymphoma
    Camus, Vincent
    Tilly, Herve
    EXPERT REVIEW OF HEMATOLOGY, 2017, 10 (12) : 1047 - 1055
  • [34] AvR-CHOP: Feasibility Study of Induction and Maintenance Avelumab Plus R- CHOP in Patients with Diffuse Large B-Cell Lymphoma (DLBCL)
    Hawkes, Eliza A.
    Manos, Kate
    Smith, Charmaine
    Hawking, Joanne
    O'Brien, Stephanie
    Churilov, Leonid
    McKendrick, Joseph
    Renwick, William
    Grigg, Andrew
    Witkowski, Tom
    Scott, Andrew
    Lee, Sze-Ting
    Lin, Wendi
    Fong, Chun
    Rooney, Carmela
    Barraclough, Allison
    Wight, Joel
    Chong, Geoff
    BLOOD, 2019, 134
  • [35] Outcome of patients with primary refractory diffuse large B cell lymphoma after R-CHOP treatment
    Hitz, Felicitas
    Connors, J. M.
    Gascoyne, R. D.
    Hoskins, P.
    Moccia, A.
    Savage, K. J.
    Sehn, L. H.
    Shenkier, T.
    Villa, D.
    Klasa, R.
    ANNALS OF HEMATOLOGY, 2015, 94 (11) : 1839 - 1843
  • [36] Evolution of R-CHOP therapy for older patients with diffuse large B-cell lymphoma
    Morrison, Vicki A.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (10) : 1651 - 1658
  • [37] Has R-CHOP Really Been Replaced as Initial Therapy of Diffuse Large B-cell Lymphoma (DLBCL)?
    Friedberg, Jonathan W.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S89 - S90
  • [38] R-CHOP compared with CHOP in patients with diffuse large B-cell lymphoma (DLCL): Russian experience
    Poddubnaya, I.
    Osmanov, E.
    Babicheva, L.
    Tumyan, G.
    Sorokin, E.
    Stefanov, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [39] Patient, Caregiver, and Physician Preferences for Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
    Vukcevic, Mirko
    Yung, Mallory
    Khan, Mali
    Houpt, Bethany
    Schnell, Frederick
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S376 - S377
  • [40] Phase II trial of split-dose R-CHOP for older patients with diffuse large B-cell lymphoma (DLBCL)
    Shah, Nirav Niranjan
    Szabo, Aniko
    Rajguru, Saurabh
    Devata, Sumana
    Howard, Mitch
    Pereira, Deepa
    Endres, Mariah
    Longo, Walter L.
    Hamadani, Mehdi
    Fenske, Timothy S.
    Fletcher, Christopher David
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345